Cited by 692Multiple Sclerosis Research StudiesNeuroinflammation and Neurodegeneration MechanismsPeripheral Neuropathies and Disorders

The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.

An updated histological classification system for multiple sclerosis lesions

Kuhlmann, Tanja, Ludwin, Samuel, Prat, Alexandre, Antel, Jack, Brück, Wolfgang, Lassmann, Hans·2017·Acta Neuropathologica

DOI 10.1007/s00401-016-1653-y

Open this paper in CoChat — free account

Abstract

Multiple sclerosis is a complex and heterogeneous, most likely autoimmune, demyelinating disease of the central nervous system (CNS). Although a number of histological classification systems for CNS lesions have been used by different groups in recent years, no uniform classification exists. In this paper, we propose a simple and unifying classification of MS lesions incorporating many elements of earlier histological systems that aims to provide guidelines for neuropathologists and researchers studying MS lesions to allow for better comparison of different studies performed with MS tissue, and to aid in understanding the pathogenesis of the disease. Based on the presence/absence and distribution of macrophages/microglia (inflammatory activity) and the presence/absence of ongoing demyelination (demyelinating activity), we suggest differentiating between active, mixed active/inactive, and inactive lesions with or without ongoing demyelination. Active lesions are characterized by macrophages/microglia throughout the lesion area, whereas mixed active/inactive lesions have a hypocellular lesion center with macrophages/microglia limited to the lesion border. Inactive lesions are almost completely lacking macrophages/microglia. Active and mixed active/inactive lesions can be further subdivided into lesions with ongoing myelin destruction (demyelinating lesions) and lesions in which the destruction of myelin has ceased, but macrophages are still present (post-demyelinating lesions). This distinction is based on the presence or absence of myelin degradation products within the cytoplasm of macrophages/microglia. For this classification of MS lesions, identification of myelin with histological stains [such as luxol fast blue-PAS] or by immunohistochemistry using antibodies against myelin basic-protein (MBP) or proteolipid-protein (PLP), as well as, detection of macrophages/microglia by, e.g., anti-CD68 is sufficient. Active and demyelinating lesions may be further subdivided into the early and late demyelinating lesions. The former is defined by the presence in macrophages of major and small molecular weight myelin proteins, such as cyclic nucleotide diphosphoesterase (CNP), myelin oligodendrocyte glycoprotein (MOG), or myelin-associated protein (MAG), whereas macrophages in the latter demonstrate merely the presence of the major myelin proteins MBP or PLP. We discuss the histological features and staining techniques required to classify MS lesions, and, in addition, describe the histological hallmarks of cortical pathology and diffuse white matter changes, as well as of remyelination.

Integrity signals

Registry

Crossref · 10.1007/s00401-016-1653-y

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Axonal transection in the lesions of multiple sclerosis
Trapp, B. D., Peterson, J., Ransohoff, R. M., Rudick, R., Mörk, S., & Bö, L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380502 · Cited by 4,029
Identification of a unique TGF-β–dependent molecular and functional signature in microglia
Butovsky, O., Jedrychowski, M. P., Moore, C. S., Cialic, R., Lanser, A. J., Gabriely, G., Koeglsperger, T., Dake, B., Wu, P. M., Doykan, C. E., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3599 · Cited by 2,543
Self-citation
Immunopathology of multiple sclerosis
Dendrou, C. A., Fugger, L., & Friese, M. A. (2015) · Nature Reviews Immunology · doi:10.1038/nri3871 · Cited by 2,215
Cortical demyelination and diffuse white matter injury in multiple sclerosis
Kutzelnigg, A., Lucchinetti, C. F., Stadelmann, C., Brück, W., Rauschka, H., Bergmann, M., Schmidbauer, M., Parisi, J. E., & Lassmann, H. (2005) · Brain · doi:10.1093/brain/awh641 · Cited by 1,836
Self-citation
The relation between inflammation and neurodegeneration in multiple sclerosis brains
Frischer, J. M., Bramow, S., Dal-Bianco, A., Lucchinetti, C. F., Rauschka, H., Schmidbauer, M., Laursen, H., Sorensen, P. S., & Lassmann, H. (2009) · Brain · doi:10.1093/brain/awp070 · Cited by 1,450
Self-citation
Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions
Peterson, J. W., Bö, L., Mörk, S., Chang, A., & Trapp, B. D. (2001) · Annals of Neurology · doi:10.1002/ana.1123 · Cited by 1,403 · cited 1×
“Lucchinetti and colleagues have shown extensive cortical inflammatory T-cell infiltrates in early MS lesions (9), however, especially in patients in the progressive disease phase, inflammatory activity in cortical lesions (especially T cells) is, in general, lower than in the adjacent white matter lesions [6, 10, 45].”
Background
Pathological mechanisms in progressive multiple sclerosis
Mahad, D., Trapp, B. D., & Lassmann, H. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70256-x · Cited by 1,198
Self-citation
Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion
Barnett, M. H., & Prineas, J. W. (2004) · Annals of Neurology · doi:10.1002/ana.20016 · Cited by 1,184
The Immunopathology of Multiple Sclerosis: An Overview
Lassmann, H., Brück, W., & Lucchinetti, C. F. (2007) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00064.x · Cited by 1,182
Self-citation
Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis
Kuhlmann, T., Miron, V., Cuo, Q., Wegner, C., Antel, J., & Bruck, W. (2008) · Brain · doi:10.1093/brain/awn096 · Cited by 864
Self-citation

Show all 59 references

Research works printed but not linked: 1

Prineas JW (1985) The neuropathology of multiple sclerosis. In: Koetsier JC (ed) Demyelinating Diseases. Elsevier Science Publishers, Amsterdam, pp 213–257

Sorted by citations

Items 201–300 of 688

Trem2 deficiency attenuates microglial phagocytosis and autophagic‐lysosomal activation in white matter hypoperfusion
Pang, X., Chu, Y., Zhou, L., Chen, M., You, Y., Tang, Y., Yang, S., Zhang, H., Xiao, J., Deng, G., et al. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15987 · Cited by 33
Molecular pathology of Multiple Sclerosis lesions reveals a heterogeneous expression pattern of genes involved in oligodendrogliogenesis
Zeis, T., Howell, O. W., Reynolds, R., & Schaeren‐Wiemers, N. (2018) · Experimental Neurology · doi:10.1016/j.expneurol.2018.03.012 · Cited by 34
Altered Expression of Ion Channels in White Matter Lesions of Progressive Multiple Sclerosis: What Do We Know About Their Function?
Boscia, F., Elkjaer, M. L., Illés, Z., & Kukley, M. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.685703 · Cited by 35
Linking immune-mediated damage to neurodegeneration in multiple sclerosis: could network-based MRI help?
Groppa, S., González‐Escamilla, G., Eshaghi, A., Meuth, S. G., & Ciccarelli, O. (2021) · Brain Communications · doi:10.1093/braincomms/fcab237 · Cited by 34
TAAR1 Expression in Human Macrophages and Brain Tissue: A Potential Novel Facet of MS Neuroinflammation
Barnes, D. A., Galloway, D. A., Hoener, M. C., Berry, M. D., & Moore, C. S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111576 · Cited by 33
Targeting Fibronectin to Overcome Remyelination Failure in Multiple Sclerosis: The Need for Brain- and Lesion-Targeted Drug Delivery
van Schaik, P. E. M., Zuhorn, I. S., & Baron, W. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158418 · Cited by 35
Single-cell and spatial RNA sequencing identify perturbators of microglial functions with aging
Dong, Y., Jain, R. W., Lozinski, B. M., D’Mello, C., Visser, F., Ghorbani, S., Zandee, S., Brown, D. I., Prat, A., Xue, M., et al. (2022) · Nature Aging · doi:10.1038/s43587-022-00205-z · Cited by 32
Self-citation
Mapping tissue microstructure across the human brain on a clinical scanner with soma and neurite density image metrics
Schiavi, S., Palombo, M., Zacà, D., Tazza, F., Lapucci, C., Castellan, L., Costagli, M., & Inglese, M. (2023) · Human Brain Mapping · doi:10.1002/hbm.26416 · Cited by 32
The Gut–Brain Axis as a Therapeutic Target in Multiple Sclerosis
Bugă, A. M., Pădureanu, V., Riza, A., Oancea, C. N., Albu, C. V., & Nica, A. D. (2023) · Cells · doi:10.3390/cells12141872 · Cited by 31
The next-generation sphingosine-1 receptor modulator BAF312 (siponimod) improves cortical network functionality in focal autoimmune encephalomyelitis
Hundehege, P., Cerina, M., Eichler, S., Thomas, C., Herrmann, A. M., Göbel, K., Müntefering, T., Fernández‐Orth, J., Böck, S., Narayanan, V., et al. (2019) · Neural Regeneration Research · doi:10.4103/1673-5374.259622 · Cited by 32
Siponimod therapy implicates Th17 cells in a preclinical model of subpial cortical injury
Ward, L. A., Lee, D. S. W., Sharma, A. K., Wang, A. A., Naouar, I., Xianjie, I., Pikor, N. B., Nuesslein‐Hildesheim, B., Ramaglia, V., & Gommerman, J. L. (2019) · JCI Insight · doi:10.1172/jci.insight.132522 · Cited by 32
MicroRNAs in gray and white matter multiple sclerosis lesions: impact on pathophysiology
Teuber‐Hanselmann, S., Meinl, E., & Junker, A. (2020) · The Journal of Pathology · doi:10.1002/path.5399 · Cited by 32
Qki is an essential regulator of microglial phagocytosis in demyelination
Ren, J., Dai, C., Zhou, X., Barnes, J. A., Chen, X., Wang, Y., Yuan, L., Shingu, T., Heimberger, A. B., Chen, Y., et al. (2021) · Journal of Experimental Medicine · doi:10.1084/jem.20190348 · Cited by 36
Circulating miRNAs as Potential Biomarkers Distinguishing Relapsing–Remitting from Secondary Progressive Multiple Sclerosis. A Review
Pietrasik, S., Dziedzic, A., Miller, E. D., Starosta, M., & Saluk, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111887 · Cited by 32
Immunopathology of Tumefactive Demyelinating Lesions-From Idiopathic to Drug-Related Cases
Vakrakou, A. G., Brinia, M.-E., Svolaki, I. P., Argyrakos, T., Stefanis, L., & Kilidireas, C. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.868525 · Cited by 32
Regulation of stress granule formation in human oligodendrocytes
Pernin, F., Cui, Q., Mohammadnia, A., Fernandes, M. G. F., Hall, J. A., Srour, M., Dudley, R., Zandee, S., Klément, W., Prat, A., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-45746-6 · Cited by 31
Self-citation
Cellular rejuvenation protects neurons from inflammation-mediated cell death
Drake, S., Mohammadnia, A., Zaman, A., Gianfelice, C., Heale, K., Groh, A. M. R., Hua, E. M.-L., Hintermayer, M. A., Lu, Y. R., Gosselin, D., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115298 · Cited by 33
Self-citation
CSF chitinase 3-like 1 is associated with iron rims in patients with a first demyelinating event
Comabella, M., Clarke, M. A., Schaedelin, S. A., Tintoré, M., Pareto, D., Fissolo, N., Pinteac, R., Granziera, C., Sastre‐Garriga, J., Benkert, P., et al. (2021) · Multiple Sclerosis Journal · doi:10.1177/13524585211010082 · Cited by 33
Effects and optimal dosage of resistance training on strength, functional capacity, balance, general health perception, and fatigue in people with multiple sclerosis: a systematic review and meta-analysis
Andreu‐Caravaca, L., Ramos‐Campo, D. J., Chung, L. H., Martínez‐Rodríguez, A., & Rubio‐Arias, J. Á. (2022) · Disability and Rehabilitation · doi:10.1080/09638288.2022.2069295 · Cited by 35
Postmortem quantitative MRI disentangles histological lesion types in multiple sclerosis
Galbusera, R., Bahn, E., Weigel, M., Schaedelin, S. A., Franz, J., Lu, P., Baraković, M., Melie‐García, L., Dechent, P., Lutti, A., et al. (2022) · Brain Pathology · doi:10.1111/bpa.13136 · Cited by 33
Self-citation
Cellxgene VIP unleashes full power of interactive visualization and integrative analysis of scRNA-seq, spatial transcriptomics, and multiome dataPreprint
Li, K., Ouyang, Z., Chen, Y., Gagnon, J., Lin, D., Mingueneau, M., Chen, W., Sexton, D., & Zhang, B. (2020) · Research Square · doi:10.1101/2020.08.28.270652 · Cited by 31
Hallmarks of spinal cord pathology in multiple sclerosis
Kreiter, D., Postma, A. A., Hupperts, R., & Gerlach, O. H. H. (2023) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2023.122846 · Cited by 33
The contribution of tumor necrosis factor to multiple sclerosis: a possible role in progression independent of relapse?
Mazziotti, V., Crescenzo, F., Turano, E., Guandalini, M., Bertolazzo, M., Ziccardi, S., Virla, F., Camera, V., Marastoni, D., Tamanti, A., et al. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03193-6 · Cited by 31
18F-THK5351 PET Can Identify Astrogliosis in Multiple Sclerosis Plaques
Ishibashi, K., Miura, Y., Hirata, K., Toyohara, J., & Ishii, K. (2019) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000002751 · Cited by 30
RNA-binding protein altered expression and mislocalization in MS
Masaki, K., Sonobe, Y., Ghadge, G. D., Pytel, P., Lépine, P., Pernin, F., Cui, Q., Antel, J. P., Zandee, S., Prat, A., et al. (2020) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000704 · Cited by 30
Self-citation
Altered PPARγ Expression Promotes Myelin-Induced Foam Cell Formation in Macrophages in Multiple Sclerosis
Wouters, E., Grajchen, E., Jorissen, W., Dierckx, T., Wetzels, S., Loix, M., Tulleners, M. P., Staels, B., Stinissen, P., Haidar, M., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239329 · Cited by 31
New Prospects for Ultra-High-Field Magnetic Resonance Imaging in Multiple Sclerosis
Ineichen, B. V., Beck, E., Piccirelli, M., & Reich, D. S. (2021) · Investigative Radiology · doi:10.1097/rli.0000000000000804 · Cited by 30
The association between neurodegeneration and local complement activation in the thalamus to progressive multiple sclerosis outcome
Cooze, B., Dickerson, M., Loganathan, R., Watkins, L. M., Grounds, E., Pearson, B., Bevan, R. J., Morgan, B. P., Magliozzi, R., Reynolds, R., et al. (2022) · Brain Pathology · doi:10.1111/bpa.13054 · Cited by 30
A Prospective Viewpoint on Neurological Diseases and Their Biomarkers
Zehravi, M., Kabir, J., Akter, R., Malik, S., Ashraf, G. M., Tagde, P., Ramproshad, S., Mondal, B., Rahman, M. H., Mohan, A. G., et al. (2022) · Molecules · doi:10.3390/molecules27113516 · Cited by 31
Effect of Evobrutinib on Slowly Expanding Lesion Volume in Relapsing Multiple Sclerosis: A Post Hoc Analysis of a Phase 2 Trial
Arnold, D. L., Elliott, C., Martin, E. C., Hyvert, Y., Tomic, D., & Montalban, X. (2024) · Neurology · doi:10.1212/wnl.0000000000208058 · Cited by 30
Disentangling the heterogeneity of multiple sclerosis through identification of independent neuropathological dimensions
de Boer, A., van den Bosch, A. M. R., Mekkes, N., Fransen, N. L., Dagkesamanskaia, E., Hoekstra, E., Hamann, J., Smolders, J., Huitinga, I., & Holtman, I. R. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02742-w · Cited by 30
CLEC16A in astrocytes promotes mitophagy and limits pathology in a multiple sclerosis mouse model
Kadowaki, A., Wheeler, M. A., Li, Z., Andersen, B. M., Lee, H., Illouz, T., Lee, J.-H., Ndayisaba, A., Zandee, S., Basu, H., et al. (2025) · Nature Neuroscience · doi:10.1038/s41593-025-01875-9 · Cited by 30
Self-citation
Csf1 Deficiency Dysregulates Glial Responses to Demyelination and Disturbs CNS White Matter Remyelination
Wylot, B., Mieczkowski, J., Niedziolka, S., Kaminska, B., & Zawadzka, M. (2019) · Cells · doi:10.3390/cells9010099 · Cited by 29
Triplanar U-Net with lesion-wise voting for the segmentation of new lesions on longitudinal MRI studies
Hitziger, S., Ling, W. X., Fritz, T., D’Albis, T., Lemke, A., & Silva, J. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.964250 · Cited by 35
Reliability of paramagnetic rim lesion classification on quantitative susceptibility mapping (QSM) in people with multiple sclerosis: Single-site experience and systematic review
Reeves, J. A., Mohebbi, M., Zivadinov, R., Bergsland, N., Dwyer, M. G., Salman, F., Schweser, F., & Jakimovski, D. (2023) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2023.104968 · Cited by 29
Update on pathology of central nervous system inflammatory demyelinating diseases
Kalinowska, A., Guo, Y., & Lucchinetti, C. F. (2022) · Neurologia i Neurochirurgia Polska · doi:10.5603/pjnns.a2022.0046 · Cited by 29
Tissue-resident memory T cells in the multiple sclerosis brain and their relationship to Epstein-Barr virus infected B cells
Serafini, B., Rosicarelli, B., Veroni, C., & Aloisi, F. (2023) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2023.578036 · Cited by 28
The prevalence and topography of spinal cord demyelination in multiple sclerosis: a retrospective study
Waldman, A. D., Catania, C., Pisa, M., Jenkinson, M., Lenardo, M. J., & DeLuca, G. C. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02700-6 · Cited by 30
Central Nervous System Barriers Impact Distribution and Expression of iNOS and Arginase-1 in Infiltrating Macrophages During Neuroinflammation
Ivan, D. C., Walthert, S., & Locatelli, G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.666961 · Cited by 27
CNS inflammation after natalizumab therapy for multiple sclerosis: A retrospective histopathological and CSF cohort study
Häusler, D., Akgün, K., Stork, L., Lassmann, H., Ziemssen, T., Brück, W., & Metz, I. (2021) · Brain Pathology · doi:10.1111/bpa.12969 · Cited by 27
Self-citation
Quantitative susceptibility mapping in multiple sclerosis: A systematic review and meta-analysis
Voon, C. C., Wiltgen, T., Wiestler, B., Schlaeger, S., & Mühlau, M. (2024) · NeuroImage Clinical · doi:10.1016/j.nicl.2024.103598 · Cited by 31
18F-PBR06 Versus 11C-PBR28 PET for Assessing White Matter Translocator Protein Binding in Multiple Sclerosis
Singhal, T., O’Connor, K., Dubey, S., Belanger, A. P., Hurwitz, S., Chu, R., Tauhid, S., Kijewski, M. F., DiCarli, M. F., Weiner, H. L., et al. (2018) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000002179 · Cited by 27
Detection of grey matter microstructural substrates of neurodegeneration in multiple sclerosis
Krijnen, E. A., Russo, A. W., Karam, E. S., Lee, H., Chiang, F. L., Schoonheim, M. M., Huang, S. Y., & Klawiter, E. C. (2023) · Brain Communications · doi:10.1093/braincomms/fcad153 · Cited by 26
CNS Resident Innate Immune Cells: Guardians of CNS Homeostasis
Muzio, L., & Perego, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25094865 · Cited by 27
DOR activation in mature oligodendrocytes regulates α-ketoglutarate metabolism leading to enhanced remyelination in aged mice
Huang, G. J., Li, Z., Liu, X., Guan, M., Zhou, S., Zhong, X., Zheng, T., Xin, D. E., Gu, X., Mu, D., et al. (2024) · Nature Neuroscience · doi:10.1038/s41593-024-01754-9 · Cited by 29
Astrocytes in the Pathogenesis of Multiple Sclerosis: An In Situ MicroRNA Study
Rao, V. T. S., Fuh, S.-C., Karamchandani, J., Woulfe, J., Muñoz, D. G., Ellezam, B., Blain, M., Ho, M., Bedell, B. J., Antel, J. P., et al. (2019) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlz098 · Cited by 26
Self-citation
Efficacy of Disease Modifying Therapies in Progressive MS and How Immune Senescence May Explain Their Failure
Manouchehri, N., Salinas, V. H., Yeganeh, N. R., Pitt, D., Hussain, R. Z., & Stüve, O. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.854390 · Cited by 26
In vivo quantification of brain soma and neurite density abnormalities in multiple sclerosis
Margoni, M., Pagani, E., Preziosa, P., Palombo, M., Gueye, M., Azzimonti, M., Filippi, M., & Rocca, M. A. (2022) · Journal of Neurology · doi:10.1007/s00415-022-11386-3 · Cited by 26
Conventional MRI-Based Structural Disconnection and Morphometric Similarity Networks and Their Clinical Correlates in Multiple Sclerosis
Tranfa, M., Petracca, M., Moccia, M., Scaravilli, A., Barkhof, F., Morra, V. B., Carotenuto, A., Collorone, S., Elefante, A., Falco, F., et al. (2025) · Neurology · doi:10.1212/wnl.0000000000213349 · Cited by 25
Imaging in mice and men: Pathophysiological insights into multiple sclerosis from conventional and advanced MRI techniques
Krämer, J., Brück, W., Zipp, F., Cerina, M., Groppa, S., & Meuth, S. G. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2019.101663 · Cited by 27
Self-citation
Effects of Biotin on survival, ensheathment, and ATP production by oligodendrocyte lineage cells in vitro
Cui, Q., Lin, Y. H., Xu, Y. K. T., Fernandes, M. G. F., Rao, V. T. S., Kennedy, T. E., & Antel, J. P. (2020) · PLoS ONE · doi:10.1371/journal.pone.0233859 · Cited by 25
Self-citation
A High MCT‐Based Ketogenic Diet Suppresses Th1 and Th17 Responses to Ameliorate Experimental Autoimmune Encephalomyelitis in Mice by Inhibiting GSDMD and JAK2‐STAT3/4 Pathways
Zhang, Q., Sun, W., Wang, Q., Zheng, X., Zhang, R., & Zhang, N. (2023) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202300602 · Cited by 25
Analysis of IL-6, IL-1β and TNF-α production in monocytes isolated from multiple sclerosis patients treated with disease modifying drugs
Fiedler, S. E., George, J. D., Love, H. N., Kim, E. J., Spain, R., BOURDETTE, D. N., & Salinthone, S. (2017) · Journal of Systems and Integrative Neuroscience · doi:10.15761/jsin.1000166 · Cited by 25
Towards a biological view of multiple sclerosis from early subtle to clinical progression: an expert opinion
Filippi, M., Amato, M. P., Avolio, C., Gallo, P., Gasperini, C., Inglese, M., Marfia, G. A., & Patti, F. (2025) · Journal of Neurology · doi:10.1007/s00415-025-12917-4 · Cited by 24
High-Resolution Transcriptomic and Proteomic Profiling of Heterogeneity of Brain-Derived Microglia in Multiple Sclerosis
Miedema, A., Wijering, M. H. C., Eggen, B. J. L., & Kooistra, S. M. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.583811 · Cited by 24
Heterogeneity of multiple sclerosis lesions in fast diffusional kurtosis imaging
Thaler, C. P., Kyselyova, A. A., Faizy, T. D., Nawka, M. T., Jespersen, S. N., Hansen, B., Stellmann, J., Heesen, C., Stürner, K. H., Stark, M., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0245844 · Cited by 24
Early Magnetic Resonance Imaging Features of New Paramagnetic Rim Lesions in Multiple Sclerosis
Clark, K. A., Manning, A. R., Chen, L., Liu, F., Cao, Q., Bar‐Or, A., Shinohara, R. T., Sweeney, E. M., & Schindler, M. K. (2023) · Annals of Neurology · doi:10.1002/ana.26727 · Cited by 24
Metabolomics of Multiple Sclerosis Lesions Demonstrates Lipid Changes Linked to Alterations in Transcriptomics-Based Cellular Profiles
Ladakis, D. C., Pedrini, E., Reyes-Mantilla, M. I., Sanjayan, M., Smith, M. D., Fitzgerald, K. C., Pardo, C. A., Reich, D. S., Absinta, M., & Bhargava, P. (2024) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000200219 · Cited by 30
Multiple sclerosis pathogenesis: missing pieces of an old puzzle
Rahmanzadeh, R., Brück, W., Minagar, A., & Sahraian, M. A. (2018) · Reviews in the Neurosciences · doi:10.1515/revneuro-2018-0002 · Cited by 28
Self-citation
Prognostic value of kappa free light chains determination in first-ever multiple sclerosis relapse
Salavisa, M., Paixão, P., Ladeira, F. F., Mendes, A., Correia, A. S., Viana, J. F., & Baptista, M. V. (2020) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2020.577355 · Cited by 24
The Distribution of GPR17-Expressing Cells Correlates with White Matter Inflammation Status in Brain Tissues of Multiple Sclerosis Patients
Angelini, J., Marangon, D., Raffaele, S., Lecca, D., & Abbracchio, M. P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094574 · Cited by 25
EBV infected cells in the multiple sclerosis brain express PD-L1: How the virus and its niche may escape immune surveillance
Serafini, B., Benincasa, L., Rosicarelli, B., & Aloisi, F. (2024) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2024.578314 · Cited by 23
Stage-dependent immunity orchestrates AQP4 antibody-guided NMOSD pathology: a role for netting neutrophils with resident memory T cells in situ
Nakajima, A., Yanagimura, F., Saji, E., Shimizu, H., Toyoshima, Y., Yanagawa, K., Arakawa, M., Hokari, M., Yokoseki, A., Wakasugi, T., et al. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02725-x · Cited by 28
Advanced MRI Techniques: Diagnosis and Follow-Up of Multiple Sclerosis
Nistri, R., Ianniello, A., Pozzilli, V., Giannì, C., & Pozzilli, C. (2024) · Diagnostics · doi:10.3390/diagnostics14111120 · Cited by 24
Iron Rims as an Imaging Biomarker in MS: A Systematic Mapping Review
AlTokhis, A. I., Alotaibi, A., Felmban, G., Constantinescu, C. S., & Evangelou, N. (2020) · Diagnostics · doi:10.3390/diagnostics10110968 · Cited by 23
Concurrent axon and myelin destruction differentiates X-linked adrenoleukodystrophy from multiple sclerosis
Bergner, C. G., Genc, N., Hametner, S., Franz, J., van der Meer, F., Mitkovski, M., Weber, M. S., Stoltenburg‐Didinger, G., Kühl, J., Köhler, W., et al. (2021) · Glia · doi:10.1002/glia.24042 · Cited by 23
Self-citation
Role of ferroptosis in neuroimmunity and neurodegeneration in multiple sclerosis revealed by multi‐omics data
Wu, T., Ning, S., Zhang, H., Cao, Y., Li, X., Hao, J., & Wang, L. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.18396 · Cited by 22
Brain-homing CD4 + T cells display glucocorticoid-resistant features in MS
Koetzier, S. C., van Langelaar, J., Blok, K. M., van den Bosch, T. P. P., Wierenga‐Wolf, A. F., Melief, M., Pol, K., Siepman, T. A. M., Verjans, G. M. G. M., Smolders, J., et al. (2020) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000894 · Cited by 22
The heterogeneity of tissue destruction between iron rim lesions and non-iron rim lesions in multiple sclerosis: A diffusion MRI study
Hu, H., Ye, L., Ding, S., Zhu, Q., Yan, Z., Chen, X., Chen, G., Xu, F., Li, Q., & Li, Y. (2022) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2022.104070 · Cited by 22
Transcriptome profiling of peripheral blood immune cell populations in multiple sclerosis patients before and during treatment with a sphingosine‐1‐phosphate receptor modulator
Angerer, I. C., Hecker, M., Koczan, D., Roch, L., Friess, J., Rüge, A., Fitzner, B., Boxberger, N., Schröder, I., Flechtner, K., et al. (2018) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12793 · Cited by 22
Immunology of oligodendrocyte precursor cells in vivo and in vitro
Antel, J. P., Lin, Y. H., Cui, Q., Pernin, F., Kennedy, T. E., Ludwin, S. K., & Healy, L. M. (2018) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2018.03.006 · Cited by 23
Self-citation
Distinct gene expression in demyelinated white and grey matter areas of patients with multiple sclerosis
van Wageningen, T. A., Gerrits, E., Brouwer, N., Brevé, J. J. P., Geurts, J. J. G., Eggen, B. J. L., Boddeke, H. W. G. M., & van Dam, A. (2022) · Brain Communications · doi:10.1093/braincomms/fcac005 · Cited by 23
Antibody cross-reactivity between casein and myelin-associated glycoprotein results in central nervous system demyelination
Chunder, R., Weier, A., Mäurer, H., Luber, N., Enders, M., Luber, G., Heider, T., Spitzer, A., Tacke, S., Becker-Gotot, J., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2117034119 · Cited by 22
Gasdermin D activation in oligodendrocytes and microglia drives inflammatory demyelination in progressive multiple sclerosis
Pollock, N. M., Fernandes, J. P., Woodfield, J., Moussa, E., Hlavay, B., Branton, W. G., Wuest, M., Mohammadzadeh, N., Schmitt, L., Plemel, J. R., et al. (2024) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2023.10.022 · Cited by 21
TSPO PET in multiple sclerosis: Emerging insights into pathophysiology, prognosis, and treatment monitoring
Guido, G., Preziosa, P., Filippi, M., & Rocca, M. A. (2025) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2025.106546 · Cited by 23
Challenge of progressive multiple sclerosis therapy
Thompson, A. J. (2017) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000453 · Cited by 21
Exploring the Pro-Phagocytic and Anti-Inflammatory Functions of PACAP and VIP in Microglia: Implications for Multiple Sclerosis
Jansen, M. I., Broome, S. T., & Castorina, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094788 · Cited by 21
Myelin histology: a key tool in nervous system research
García‐García, Ó. D., Carriel, V., & Chato‐Astrain, J. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.375318 · Cited by 21
Galectin-4, a Negative Regulator of Oligodendrocyte Differentiation, Is Persistently Present in Axons and Microglia/Macrophages in Multiple Sclerosis Lesions
de Jong, C. G. H. M., Stancic, M., Pinxterhuis, T. H., van Horssen, J., van Dam, A., Gabius, H., & Baron, W. (2018) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nly081 · Cited by 21
HMGB1 as a potential new marker of disease activity in patients with multiple sclerosis
Bucová, M., Majernikova, B., Ďurmanová, V., Čopíková‐Cudráková, D., Gmitterová, K., Lisa, I., Klímová, E., Klučková, K., & Buc, M. (2019) · Neurological Sciences · doi:10.1007/s10072-019-04136-3 · Cited by 21
Amide Proton Transfer Weighted Imaging Shows Differences in Multiple Sclerosis Lesions and White Matter Hyperintensities of Presumed Vascular Origin
Sartoretti, E., Sartoretti, T., Wyss, M., Becker, A. S., Schwenk, Á., van Smoorenburg, L., Najafi, A., Binkert, C. A., Thoeny, H. C., Zhou, J., et al. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.01307 · Cited by 21
Connecting Immune Cell Infiltration to the Multitasking Microglia Response and TNF Receptor 2 Induction in the Multiple Sclerosis Brain
Veroni, C., Serafini, B., Rosicarelli, B., Fagnani, C., Aloisi, F., & Agresti, C. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00190 · Cited by 21
Microglia depletion as a therapeutic strategy: friend or foe in multiple sclerosis models?
Mancini, V. S. B. W., Pietro, A. A. D., & Pasquini, L. A. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.346538 · Cited by 20
Central and peripheral myeloid-derived suppressor cell-like cells are closely related to the clinical severity of multiple sclerosis
Ortega, M. C., Lebrón‐Galán, R., Machín-Díaz, I., Naughton, M., Pérez-Molina, I., García-Arocha, J., García‐Domínguez, J. M., Goicoechea-Briceño, H., Sol, V. V., Quintanero-Casero, V., et al. (2023) · Acta Neuropathologica · doi:10.1007/s00401-023-02593-x · Cited by 22
Mechanisms of metabolic stress induced cell death of human oligodendrocytes: relevance for progressive multiple sclerosis
Fernandes, M. G. F., Mohammadnia, A., Pernin, F., Schmitz-Gielsdorf, L. E., Hodgins, C., Cui, Q., Yaqubi, M., Blain, M., Hall, J. A., Dudley, R., et al. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01601-1 · Cited by 20
Self-citation
Insights into the Role of Neuroinflammation in the Pathogenesis of Multiple Sclerosis
Al‐Badri, G., & Castorina, A. (2018) · Journal of Functional Morphology and Kinesiology · doi:10.3390/jfmk3010013 · Cited by 20
Increased CCL18 plasma levels are associated with neurodegenerative MRI outcomes in multiple sclerosis patients
Ziliotto, N., Bernardi, F., Jakimovski, D., Baroni, M., Bergsland, N., Ramasamy, D. P., Weinstock‐Guttman, B., Zamboni, P., Marchetti, G., Zivadinov, R., et al. (2018) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2018.07.009 · Cited by 20
Microglia from patients with multiple sclerosis display a cell-autonomous immune activation state
Hyvärinen, T., Lotila, J., Giudice, L., Tujula, I., Nylund, M., Ohtonen, S., Scoyni, F., Jäntti, H., Virtanen, L., Pihlava, S., et al. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03575-4 · Cited by 19
Rim lesions are demonstrated in early relapsing–remitting multiple sclerosis using 3 T-based susceptibility-weighted imaging in a multi-institutional setting
Kwong, K. C. N. K., Mollison, D., Meijboom, R., York, E. N., Kampaite, A., Martin, S., Hunt, D. P. J., Thrippleton, M. J., Chandran, S., & Waldman, A. D. (2021) · Neuroradiology · doi:10.1007/s00234-021-02768-x · Cited by 19
Serum neurofilament light chain correlates with myelin and axonal magnetic resonance imaging markers in multiple sclerosis
Yik, J. T., Becquart, P., Gill, J., Petkau, J., Traboulsee, A. L., Carruthers, R. L., Kolind, S., Devonshire, V. A., Sayao, A., Schabas, A. J., et al. (2021) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2021.103366 · Cited by 21
Phloroglucinol derivative compound 21 attenuates cuprizone-induced multiple sclerosis mice through promoting remyelination and inhibiting neuroinflammation
Zhao, Z., Bao, X.-Q., Zhang, Z., Liu, H., & Zhang, D. (2019) · Science China Life Sciences · doi:10.1007/s11427-019-9821-2 · Cited by 20
Perivascular tissue resident memory T cells as therapeutic target in multiple sclerosis
Smolders, J., Fransen, N. L., Hsiao, C., Hamann, J., & Huitinga, I. (2020) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2020.1776609 · Cited by 22
VISTA regulates microglia homeostasis and myelin phagocytosis, and is associated with MS lesion pathology
Borggrewe, M., Kooistra, S. M., Wesseling, E. M., Gierschek, F. L., Brummer, M. L., Nowak, E. C., Medeiros-Furquim, T., Otto, T. A., Lee, S. W., Noelle, R. J., et al. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01186-7 · Cited by 20
Implications of immunometabolism for smouldering MS pathology and therapy
Bittner, S., Pape, K., Klotz, L., & Zipp, F. (2023) · Nature Reviews Neurology · doi:10.1038/s41582-023-00839-6 · Cited by 19
Multiple sclerosis severity variant in DYSF-ZNF638 locus associates with neuronal loss and inflammation
Engelenburg, H. J., van den Bosch, A. M. R., Chen, J. Q. A., Hsiao, C., Melief, M., Harroud, A., Huitinga, I., Hamann, J., & Smolders, J. (2025) · iScience · doi:10.1016/j.isci.2025.112430 · Cited by 18
Imaging cortical lesions in multiple sclerosis
Mainero, C., Treaba, C. A., & Barbuti, E. (2023) · Current Opinion in Neurology · doi:10.1097/wco.0000000000001152 · Cited by 19
The Plasticity of Immune Cell Response Complicates Dissecting the Underlying Pathology of Multiple Sclerosis
Sarkar, S. K., Willson, A. M. L., & Jordan, M. A. (2024) · Journal of Immunology Research · doi:10.1155/2024/5383099 · Cited by 19
New Imaging Markers in Multiple Sclerosis and Related Disorders
Hemond, C. C., Gaitán, M. I., Absinta, M., & Reich, D. S. (2024) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2024.03.004 · Cited by 18
TSPO-PET Imaging to Assess Cerebral Microglial Activation in Multiple Sclerosis
Weiner, H. L., Bakshi, R., & Singhal, T. (2017) · Seminars in Neurology · doi:10.1055/s-0037-1608715 · Cited by 18
Multiple sclerosis with atypical MRI presentation: Results of a nationwide multicenter study in 57 consecutive cases
Codjia, P., Ayrignac, X., Dalliere, C. C., Cohen, M., Charif, M., Lippi, A., Collongues, N., Corti, L., Seze, J. D., Lebrun‐Frénay, C., et al. (2018) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2018.12.022 · Cited by 20

Authors: Kuhlmann, T., Ludwin, S., Prat, A., Antel, J., Brück, W., & Lassmann, H.
Affiliations: University Hospital Münster (DE)
Montreal Neurological Institute and Hospital (CA)
Centre Hospitalier de l’Université de Montréal (CA)
Universitätsmedizin Göttingen (DE)
Medical University of Vienna (AT)
Corresponding author: Kuhlmann, Tanja
ORCID: Kuhlmann, Tanja
Prat, Alexandre
Antel, Jack
Brück, Wolfgang
Lassmann, Hans
Venue: Acta Neuropathologica
Publisher: Springer Science and Business Media LLC
Published: 2016-12-17
Volume: 133
Issue: 1
Pages: 13-24
ISSN: 0001-6322 (ISSN-L)
1432-0533
DOI: 10.1007/s00401-016-1653-y
OpenAlex: W2562977489
Cited by: 692
References: 59
Citations by year: 2026: 58 · 2025: 87 · 2024: 113 · 2023: 81 · 2022: 99 · 2021: 83 · 2020: 59 · 2019: 51 · 2018: 42 · 2017: 17
FWCI: 33.28
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (unspecified)
Locations: Acta Neuropathologica (publishedVersion)
PubMed (publishedVersion)
GRO (submittedVersion)
Funders: Deutsche Forschungsgemeinschaft (SFB-TRR128 B-7, Ku1477/6-1)
IZKF (KuT3/012/15)
Austrian Science Fund (FWF Project I 2114-B27)
CIHR; Quebec, FRQS
CIHR, Quebec, FRQS
BMBF, KKNMS
Topics: Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
Keywords: multiple sclerosis, histological classification, demyelination, macrophages, microglia, active lesions, myelin basic protein, proteolipid protein, myelin oligodendrocyte glycoprotein, myelin-associated glycoprotein, cortical pathology, remyelination, demyelinating disease, central nervous system lesions, neuropathology
MeSH terms: Animals, Humans, Macrophages, Multiple Sclerosis, Microglia, White Matter

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

An updated histological classification system for multiple sclerosis lesions

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks